Claims
- 1. An isolated polynucleotide comprising a first nucleotide sequence encoding a polypeptide of at least 40 amino acids that has at least 85% identity based on the Clustal method of alignment when compared to a polypeptide selected from the group consisting of SEQ ID NOs:2, 4, 6, 30, 32, and 34,
or a second nucleotide sequence comprising the complement of the first nucleotide sequence.
- 2. An isolated polynucleotide comprising a first nucleotide sequence encoding a polypeptide of at least 150 amino acids that has at least 95% identity based on the Clustal method of alignment when compared to a polypeptide selected from the group consisting of SEQ ID NOs:8, 10, 36, and 38,
or a second nucleotide sequence comprising the complement of the first nucleotide sequence.
- 3. An isolated polynucleotide comprising a first nucleotide sequence encoding a polypeptide of at least 200 amino acids that has at least 80% identity based on the Clustal method of alignment when compared to a polypeptide selected from the group consisting of SEQ ID NOs:12 and 40,
or a second nucleotide sequence comprising the complement of the first nucleotide sequence.
- 4. An isolated polynucleotide comprising a first nucleotide sequence encoding a polypeptide of at least 175 amino acids that has at least 95% identity based on the Clustal method of alignment when compared to a polypeptide selected from the group consisting of SEQ ID NOs:14, 16, 18, 42, 44, and 46,
or a second nucleotide sequence comprising the complement of the first nucleotide sequence.
- 5. An isolated polynucleotide comprising a first nucleotide sequence encoding a polypeptide selected from the group consisting of SEQ ID NOs:20, 22, 24, 26, 28, 48, 50, 52, 54, and 56,
or a second nucleotide sequence comprising the complement of the first nucleotide sequence.
- 6. The isolated polynucleotide of claim 1, claim 2, claim 3, claim 4, or claim 5, wherein the first nucleotide sequence consists of a nucleic acid sequence selected from the group consisting of SEQ ID NOs:1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, and 55 that codes for the polypeptide selected from the group consisting of SEQ ID NOs:2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, and 56.
- 7. The isolated polynucleotide of claim 1, claim 2, claim 3, claim 4, or claim 5 wherein the nucleotide sequences are DNA.
- 8. The isolated polynucleotide of claim 1, claim 2, claim 3, claim 4, or claim 5 wherein the nucleotide sequences are RNA.
- 9. A chimeric gene comprising the isolated polynucleotide of claim 1, claim 2, claim 3, claim 4, or claim 5 operably linked to suitable regulatory sequences.
- 10. An isolated host cell comprising the chimeric gene of claim 9.
- 11. A host cell comprising an isolated polynucleotide of claim 1, claim 2, claim 3, claim 4, or claim 5.
- 12. The host cell of claim 11 wherein the host cell is selected from the group consisting of yeast, bacteria, plant, and virus.
- 13. A virus comprising the isolated polynucleotide of claim 1, claim 2, claim 3, claim 4, or claim 5.
- 14. A polypeptide of at least 40 amino acids that has at least 85% identity based on the Clustal method of alignment when compared to a polypeptide selected from the group consisting of SEQ ID NOs:2, 4, 6, 30, 32, and 34.
- 15. A polypeptide of at least 150 amino acids that has at least 95% identity based on the Clustal method of alignment when compared to a polypeptide selected from the group consisting of SEQ ID NOs:8, 10, 36, and 38.
- 16. A polypeptide of at least 200 amino acids that has at least 80% identity based on the Clustal method of alignment when compared to a polypeptide selected from the group consisting of SEQ ID NOs:12 and 40.
- 17. A polypeptide of at least 175 amino acids that has at least 95% identity based on the Clustal method of alignment when compared to a polypeptide selected from the group consisting of SEQ ID NOs:14, 16, 18, 42, 44, and 46.
- 18. A polypeptide selected from the group consisting of SEQ ID NOs:20, 22, 24, 26, 28, 48, 50, 52, 54, and 56.
- 19. A method of selecting an isolated polynucleotide that affects the level of expression of a proteinase polypeptide in a plant cell, the method comprising the steps of:
(a) constructing an isolated polynucleotide comprising a nucleotide sequence of at least one of 30 contiguous nucleotides derived from an isolated polynucleotide of claim 1, claim 2, claim 3, claim 4, or claim 5; (b) introducing the isolated polynucleotide into a plant cell; (c) measuring the level of a polypeptide in the plant cell containing the polynucleotide; and (d) comparing the level of polypeptide in the plant cell containing the isolated polynucleotide with the level of polypeptide in a plant cell that does not contain the isolated polynucleotide.
- 20. The method of claim 19 wherein the isolated polynucleotide consists of a nucleotide sequence selected from the group consisting of SEQ ID NOs:1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, and 55 that codes for the polypeptide selected from the group consisting of SEQ ID NOs:2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, and 56.
- 21. A method of selecting an isolated polynucleotide that affects the level of expression of a proteinase polypeptide in a plant cell, the method comprising the steps of:
(a) constructing an isolated polynucleotide of claim 1, claim 2, claim 3, claim 4, or claim 5; (b) introducing the isolated polynucleotide into a plant cell; (c) measuring the level of polypeptide in the plant cell containing the polynucleotide; and (d) comparing the level of polypeptide in the plant cell containing the isolated polynucleotide with the level of polypeptide in a plant cell that does not contain the polynucleotide.
- 22. A method of obtaining a nucleic acid fragment encoding a proteinase polypeptide comprising the steps of:
(a) synthesizing an oligonucleotide primer comprising a nucleotide sequence of at least one of 30 contiguous nucleotides derived from a nucleotide sequence selected from the group consisting of SEQ ID NOs:1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, and 55 and the complement of such nucleotide sequences; and (b) amplifying a nucleic acid sequence using the oligonucleotide primer.
- 23. A method of obtaining a nucleic acid fragment encoding a proteinase polypeptide comprising the steps of:
(a) probing a cDNA or genomic library with an isolated polynucleotide comprising at least one of 30 contiguous nucleotides derived from a nucleotide sequence selected from the group consisting of SEQ ID NOs:1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, and 55 and the complement of such nucleotide sequences; (b) identifying a DNA clone that hybridizes with the isolated polynucleotide; (c) isolating the identified DNA clone; and (d) sequencing the cDNA or genomic fragment that comprises the isolated DNA clone.
- 24. A composition comprising the isolated polynucleotide of claim 1, claim 2, claim 3, claim 4, or claim 5.
- 25. A composition comprising the isolated polynucleotide of claim 14, claim 15, claim 16, claim 17, or claim 18.
- 26. An isolated polynucleotide comprising the nucleotide sequence having at least one of 30 contiguous nucleotides derived from a nucleic acid sequence selected from the group consisting of SEQ ID NOs:1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, and 55 and the complement of such sequences.
- 27. An expression cassette comprising an isolated polynucleotide of claim 1, claim 2, claim 3, claim 4, or claim 5 operably linked to a promoter.
- 28. A method for positive selection of a transformed cell comprising:
(a) transforming a host cell with the chimeric gene of claim 9 or an expression cassette of claim 27; and (b) growing the transformed host cell under conditions which allow expression of the polynucleotide.
- 29. The method of claim 28 wherein the plant cell is a monocot.
- 30. The method of claim 28 wherein the plant cell is a dicot.
Parent Case Info
[0001] This application claims the benefit of U.S. Provisional Application No. 60/119,599, filed Feb. 10, 1999.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60119599 |
Feb 1999 |
US |
Continuations (1)
|
Number |
Date |
Country |
Parent |
09501423 |
Feb 2000 |
US |
Child |
10076785 |
Feb 2002 |
US |